Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/21/2025

Emotional Blunting with Qelbree (Viloxazine)

Understanding the Condition

  • ADHD frequently co-occurs with mood disorders, and what feels like medication-induced blunting may actually be untreated or emerging depression, according to the American Academy of Child and Adolescent Psychiatry 1

Treatment Considerations

  • The therapeutic effects of viloxazine may not be fully evident until 2-4 weeks after initiation, though some benefits appear by week 2, as noted by Praxis Medical Insights 2
  • Stimulants show larger effect sizes for ADHD core symptoms and have different side effect profiles, which may be considered if emotional blunting is confirmed as medication-related 4
  • Cognitive-behavioral therapy can address both ADHD-related impairments and mood symptoms without additional medication burden, as recommended by the American Academy of Child and Adolescent Psychiatry 1

Management of Side Effects

  • Don't discontinue viloxazine abruptly without medical guidance, work with your prescriber to determine the appropriate course of action, as advised by Praxis Medical Insights 2

REFERENCES

2

Qelbree Administration and Monitoring [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Medication Addition to Existing Regimen [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025